Facile synthesis of Gd(iii) metallosurfactant-functionalized carbon nanodots with high relaxivity as bimodal imaging probes

RSC Advances ◽  
2016 ◽  
Vol 6 (35) ◽  
pp. 29441-29447 ◽  
Author(s):  
Qin Zhu ◽  
Fei Pan ◽  
Yu Tian ◽  
Weijun Tang ◽  
Yuan Yuan ◽  
...  

Fluorescence and magnetic resonance (MR) dual-modal imaging contrast agents were prepared by the ionic self-assembly of carbon nanodots (CDs) and gadolinium(iii)-containing metallosurfactants (MS).

2010 ◽  
Vol 10 (1) ◽  
pp. 540-548 ◽  
Author(s):  
Kui Luo ◽  
Jing Tian ◽  
Gang Liu ◽  
Jiayu Sun ◽  
Chunchao Xia ◽  
...  

2005 ◽  
Vol 54 (4) ◽  
pp. 807-812 ◽  
Author(s):  
Mark Allen ◽  
Jeff W. M. Bulte ◽  
Lars Liepold ◽  
Gautam Basu ◽  
Holly A. Zywicke ◽  
...  

2018 ◽  
Vol 38 (7) ◽  
pp. 1779
Author(s):  
Hongshun Sun ◽  
Yulong Li ◽  
Hong Jiang ◽  
Cheng Guo ◽  
Linjiang Shen

2020 ◽  
Vol 49 (26) ◽  
pp. 8927-8932
Author(s):  
Kehan Xu ◽  
Na Xu ◽  
Beibei Zhang ◽  
Weijun Tang ◽  
Yun Ding ◽  
...  

Macrocyclic gadolinium(iii) complexes with hyphenated-amino-N-oxide (HAO) type ligand structures are designed as efficient magnetic resonance imaging (MRI) contrast agents (CAs) with high relaxivity and stability.


2009 ◽  
Vol 4 (2) ◽  
pp. 98 ◽  
Author(s):  
Nicoletta Anzalone ◽  

Gadolinium-based contrast agents (GBCAs) are commonly used to enhance image acquisition via magnetic resonance imaging, but they differ in their physicochemical characteristics and therefore their function. The stability, concentration and relaxivity of a GBCA can have a major impact on clinical efficacy. Stability is related to safety. GBCAs can be categorised into three stability classes: non-ionic linear agents, ionic linear agents and macrocyclic agents, in order of increasing stability. Relaxivity and concentration are contributing factors to the level of enhancement that can be achieved with any given GBCA. Gadobutrol, gadobenate and gadoxetic acid have relatively high relaxivities. Among these compounds, only gadobutrol is commercially available at a higher concentration of 1.0M, whereas the others are used at a standard concentration of 0.5M. With high stability, relaxivity and concentration, gadobutrol has been shown in a number of clinical studies to be safe while improving image enhancement with increased conspicuity and sensitivity over other commonly used GBCAs.


2014 ◽  
Vol 18 (10n11) ◽  
pp. 950-959 ◽  
Author(s):  
Xian-Sheng Ke ◽  
Juan Tang ◽  
Zi-Shu Yang ◽  
Jun-Long Zhang

Synthesis of two bimodal imaging agents consist of a hydrophobic zinc(II) tetrapentafluorophenylporpholactol core and a β-substituted hydrophilic Gd ( III ) DO3A (ZnLGd539) or DOTA (ZnLGd595) like moiety has been described (DO3A = 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid, DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid). Through β-conjugation approach, the absorption at deep red region increases compared to traditional conjugation methods at meso-position. More importantly, these new complexes possess largely improved ionic relaxitivites relative to the sole Gd ( III ) magnetic resonance imaging (MRI) agents such as Gd ( III ) DO3A and Gd ( III ) DOTA like complexes. Combining the optical and magnetic resonance measurements in aqueous media, the largely enhanced r1 relaxivities was attributed to the aggregation of ZnLGd539 and ZnLGd595 in aqueous media. Furthermore, fluorescence and magnetic resonance imaging experiment showed that both ZnLGd539 and ZnLGd595 can be applied as potential bimodal imaging contrast agents. Finally, both compounds showed no dark cytotoxicity and good photocytotoxicity (IC50 = 1.73 ± 0.13 and 1.52 ± 0.10 μM for ZnLGd539 and ZnLGd595 respectively) on Hela cells.


Sign in / Sign up

Export Citation Format

Share Document